{"schema":"rootz.ai/filing-signals/v1","query":{"ticker":"CC","limit":50},"count":50,"signals":[{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":54,"context":"business on March2, 2026 are entitled to notice of, and to vote at, the Annual Meeting, and any adjournments or postponements of the Annual Meeting. By Order of the Board of Directors KRISTINE M. WELLMAN Senior Vice President, General Counsel & Corporate Secretary March10, 2026 YOUR VOTE IS IMPORTANT. Even if you plan to attend the Annual Meeting, we still encourage you to submit your proxy via","filed_date":"2026-03-10","accession":"0001104659-26-025935","full_text":"https://origin.rootz.global/static/filing/0001104659-26-025935.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":37,"context":"nd, in consultation with the CLDCs independent compensation consultant, determined its compensation programs do not encourage or create excessive risk-taking, and none are reasonably likely to have a material adverse effect on the Company. In conducting this assessment, the components and design features of executive and non-executive plans and programs were analyzed. A summary of the findings of the assessment was pro","filed_date":"2026-03-10","accession":"0001104659-26-025935","full_text":"https://origin.rootz.global/static/filing/0001104659-26-025935.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":22,"context":"rough the announced exit of the SPS Capstone business at our Villers-St. Paul site in France and consolidated manufacturing of our Viton fluoroelastomers at our Chambers Works site. The business also entered into a strategic agreement with SRF Limited in India to provide additional strength and flexibility to our operating footprint to support market needs for essential applications. In early 2026, Titanium Technologies (TT) annou","filed_date":"2026-03-10","accession":"0001104659-26-025935","full_text":"https://origin.rootz.global/static/filing/0001104659-26-025935.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":20,"context":"related, and other charges were primarily attributable to $27 million of non-cash asset-related charges, $20 million of employee separation charges and $3 million of other charges related to the 2024 Restructuring Program initialed in the third quarter of 2024. In addition, for the year ended December 31, 2024, charges included $11 million of decommissioning and other charges related to the Titanium Technologies Trans","filed_date":"2026-02-24","accession":"0001193125-26-065201","full_text":"https://origin.rootz.global/static/filing/0001193125-26-065201.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":93,"context":"our results of operations could be negatively affected; Effects of price fluctuations in energy and raw materials, our raw materials contracts, and our inability to renew such contracts, could have a significant negative impact on our operating results; Our reported results and financial condition could be adversely affected by currency exchange rates and currency devaluation could impair our competitiveness; If our long-li","filed_date":"2026-02-24","accession":"0001193125-26-065201","full_text":"https://origin.rootz.global/static/filing/0001193125-26-065201.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":12,"context":"ours Company Notes to the Consolidated Financial Statements (Dollars in millions, except per share amounts and par values) Note 4. Acquisitions and Divestitures Divestitures In June 2023, the Company entered into a definitive agreement with PureTech Scientific Inc. to sell the Company's Glycolic Acid business, included in the Company's Other Segment, for cash consideration of approximately $137 (the Glycolic Acid Transaction). The","filed_date":"2026-02-24","accession":"0001193125-26-065201","full_text":"https://origin.rootz.global/static/filing/0001193125-26-065201.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":17,"context":"ion charges | | | | | | | | | | | | | | | | | | | | | SPS CapstoneTMExit | | $ | | | | $ | | | | $ | (1 | ) | | $ | | | | $ | | | | $ | (1 | ) | | | 2024 Restructuring Program | | | | | | | | | | | | | | | | | | | | | | | | | | | Total employee separation charges | | | | | | | | | | | (1 | ) | | | | | | | | | | | (1 | ) |","filed_date":"2025-11-06","accession":"0001193125-25-269765","full_text":"https://origin.rootz.global/static/filing/0001193125-25-269765.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":46,"context":"ness on February28, 2025 are entitled to notice of, and to vote at, the Annual Meeting, and any adjournments or postponements of the Annual Meeting. By Order of the Board of Directors Kristine M. Wellman Senior Vice President, General Counsel & Corporate Secretary March 20, 2025 Your vote is important. Even if you plan to attend the Annual Meeting, we still encourage you to submit your proxy via","filed_date":"2025-03-20","accession":"0001104659-25-025816","full_text":"https://origin.rootz.global/static/filing/0001104659-25-025816.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":30,"context":"concurrence with the CLDCs independent compensation consultant, determined that none of its compensation programs encourages or creates excessive risk-taking, and none are reasonably likely to have a material adverse effect on the Company. In conducting this assessment, the components and design features of executive and non-executive plans and programs were analyzed. A summary of the findings of the assessment was pro","filed_date":"2025-03-20","accession":"0001104659-25-025816","full_text":"https://origin.rootz.global/static/filing/0001104659-25-025816.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":27,"context":"anying Proxy Statement to serve one-year terms expiring at the Annual Meeting of Shareholders in 2026; | | | | | 2. | | | To hold a non-binding advisory vote to approve the compensation of our named executive officers; | | | | | 3. | | | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2025; | | | | | 4. | | | To approve amend","filed_date":"2025-03-20","accession":"0001104659-25-025816","full_text":"https://origin.rootz.global/static/filing/0001104659-25-025816.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":18,"context":"related, and other charges were primarily attributable to $27 million of non-cash asset-related charges, $20 million of employee separation charges and $3 million of other charges related to the 2024 Restructuring Program initialed in the third quarter of 2024. In addition, for the year ended December 31, 2024, charges included $11 million of decommissioning and other charges related to the Titanium Technologies Trans","filed_date":"2025-02-18","accession":"0000950170-25-021787","full_text":"https://origin.rootz.global/static/filing/0000950170-25-021787.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":84,"context":"our results of operations could be negatively affected; Effects of price fluctuations in energy and raw materials, our raw materials contracts, and our inability to renew such contracts, could have a significant negative impact on our earnings; Our reported results and financial condition could be adversely affected by currency exchange rates and currency devaluation could impair our competitiveness; If we are unable to inn","filed_date":"2025-02-18","accession":"0000950170-25-021787","full_text":"https://origin.rootz.global/static/filing/0000950170-25-021787.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":18,"context":"ours Company Notes to the Consolidated Financial Statements (Dollars in millions, except per share amounts and par values) Note 4. Acquisitions and Divestitures Divestitures In June 2023, the Company entered into a definitive agreement with PureTech Scientific Inc. to sell the Company's Glycolic Acid business, included in the Company's Other Segment, for cash consideration of approximately $137 (the Glycolic Acid Transaction). The","filed_date":"2025-02-18","accession":"0000950170-25-021787","full_text":"https://origin.rootz.global/static/filing/0000950170-25-021787.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":22,"context":"| | Three Months Ended September 30, 2024 | | | | | | | | | | | | | | | | | | | | | Employee separation charges | | | | | | | | | | | | | | | | | | | | | 2024 Restructuring Program | | $ | | | | $ | | | | $ | 13 | | | $ | | | | $ | 5 | | | $ | 18 | | | | Total employee separation charges | | | | | | | | | | | 13 | | | | | | | | 5 |","filed_date":"2024-11-04","accession":"0000950170-24-120270","full_text":"https://origin.rootz.global/static/filing/0000950170-24-120270.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":49,"context":"business on April3, 2024 are entitled to notice of, and to vote at, the Annual Meeting, and any adjournments or postponements of the Annual Meeting. By Order of the Board of Directors Kristine M. Wellman Senior Vice President, General Counsel & Corporate Secretary April11, 2024 Your vote is important. Even if you plan to attend the Annual Meeting, we still encourage you to submit your proxy via","filed_date":"2024-04-11","accession":"0001104659-24-046287","full_text":"https://origin.rootz.global/static/filing/0001104659-24-046287.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":13,"context":"concurrence with the CLDCs independent compensation consultant, determined that none of its compensation programs encourages or creates excessive risk-taking, and none are reasonably likely to have a material adverse effect on the Company. In conducting this assessment, the components and design features of executive and non-executive plans and programs were analyzed. A summary of the findings of the assessment was pro","filed_date":"2024-04-11","accession":"0001104659-24-046287","full_text":"https://origin.rootz.global/static/filing/0001104659-24-046287.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":37,"context":"t outside counsel. These actions included swiftly announcing leadership changes after placing three members of senior management on administrative leave in late February. On March22, 2024, the Board appointed Denise Dignam as President and Chief Executive Officer. As a long-tenured senior executive, Denise has been instrumental to Chemours and has led both our Titanium Technologies and Advanced Performance Materials businesses, whi","filed_date":"2024-04-11","accession":"0001104659-24-046287","full_text":"https://origin.rootz.global/static/filing/0001104659-24-046287.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":12,"context":"| | | | | | | | | | | | | | | | | | Titanium Technologies Transformation Plan | | $ | 21 | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | 21 | | | | 2023 Restructuring Program | | | | | | | | | | | 3 | | | | | | | | 1 | | | | 4 | | | | 2022 Restructuring Programs | | | | | | | 1 | | | | (1 | ) | | | | | | | (1 | ) | | | (1 |","filed_date":"2024-03-27","accession":"0000950170-24-037171","full_text":"https://origin.rootz.global/static/filing/0000950170-24-037171.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":78,"context":"inancial and non-financial targets could negatively impact the value of our business and adversely affect our stock price; and A pandemic, epidemic, or other outbreak of infectious disease may have a material adverse effect on our business operations, results of operations, financial condition, and cash flows. 16 The Chemours Company Risks Related to Our Operations Our ability to make future strategic decisions regardin","filed_date":"2024-03-27","accession":"0000950170-24-037171","full_text":"https://origin.rootz.global/static/filing/0000950170-24-037171.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":15,"context":"ed March 31, 2023 and provided the required disclosure for the year ended December 31, 2023 in \"Note 18 Accounts Payable\". Note 4. Acquisitions and Divestitures Divestitures In June 2023, the Company entered into a definitive agreement with PureTech Scientific Inc. to sell the Company's Glycolic Acid business, included in the Company's Other Segment, for cash consideration of approximately $137 (the Glycolic Acid Transaction). The","filed_date":"2024-03-27","accession":"0000950170-24-037171","full_text":"https://origin.rootz.global/static/filing/0000950170-24-037171.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":35,"context":"tutions | 187 | | | SECTION 9.20. | | Acknowledgement Regarding Any Supported QFCs | 187 | | | | | | | | | | | SCHEDULES: | | | | Schedule 1.01 | [Reserved] | | | Schedule 1.02 | Material Adverse Effect | | | Schedule 1.03 | Mortgaged Property | | | Schedule 2.01 | Commitments | | | Schedule 2.04 | Swingline Commitments | | | Schedule 3.05 | Real Property | | | Schedule 3.06 | Litigat","filed_date":"2023-08-23","accession":"0000950170-23-044181","full_text":"https://origin.rootz.global/static/filing/0000950170-23-044181.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":23,"context":"usiness on March1, 2023 are entitled to notice of, and to vote at, the Annual Meeting, and any adjournments or postponements of the Annual Meeting. By Order of the Board of Directors. Kristine M. Wellman Senior Vice President, General Counsel & Corporate Secretary March10, 2023 Your vote is important. Even if you plan to attend the Annual Meeting, we still encourage you to submit your proxy via","filed_date":"2023-03-10","accession":"0001104659-23-031249","full_text":"https://origin.rootz.global/static/filing/0001104659-23-031249.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":13,"context":"concurrence with the CLDCs independent compensation consultant, determined that none of its compensation programs encourages or creates excessive risk-taking, and none are reasonably likely to have a material adverse effect on the Company. In conducting this assessment, the components and design features of executive and non-executive plans and programs were analyzed. A summary of the findings of the assessment was pro","filed_date":"2023-03-10","accession":"0001104659-23-031249","full_text":"https://origin.rootz.global/static/filing/0001104659-23-031249.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":26,"context":"med in the accompanying Proxy Statement to serve one-year terms expiring at the Annual Meeting of Shareholders in 2024; | | | To hold a non-binding advisory vote to approve the compensation of our named executive officers; | | | To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year 2023; and | | | To transact such other business that may prope","filed_date":"2023-03-10","accession":"0001104659-23-031249","full_text":"https://origin.rootz.global/static/filing/0001104659-23-031249.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":12,"context":"3 The Chemours Company Notes to the Consolidated Financial Statements (Dollars in millions, except per share amounts and par values) The following table sets forth the impacts of the Company’s restructuring programs to segment earnings for the years ended December 31, 2022, 2021 and 2020. | | | | | | | | | | | | | | | | | | Year Ended December 31, | | | | | | 2022 | | | 2021 | | | 2","filed_date":"2023-02-10","accession":"0000950170-23-002467","full_text":"https://origin.rootz.global/static/filing/0000950170-23-002467.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":31,"context":"ies alleging harm to the general public and damages to natural resources. Various factors or developments in these nationwide trends or in the actions could result in future charges that could have a material adverse effect on us. An adverse outcome in any one or more of these matters could be material to our financial results, liquidity, and/or stock price, and could adversely impact the value of any of our brands that","filed_date":"2023-02-10","accession":"0000950170-23-002467","full_text":"https://origin.rootz.global/static/filing/0000950170-23-002467.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":16,"context":"rded a net pre-tax gain of $5 and $18, respectively, in other income (expense), net in the consolidated statements of operations during the year ended December 31, 2022. On July 26, 2021, the Company entered into a definitive agreement with Manchester Acquisition Sub LLC, a Delaware limited liability company and a subsidiary of Draslovka Holding a.s., to sell the Mining Solutions business of its Chemical Solutions segment for cash","filed_date":"2023-02-10","accession":"0000950170-23-002467","full_text":"https://origin.rootz.global/static/filing/0000950170-23-002467.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"ai_adoption","strength":100,"match_count":15,"context":"of each Committee are summarized below. Audit Committee The responsibilities of the Audit Committee are more fully described in the Audit Committee Charter and include, among other duties, the fulfillment of its and the Boards oversight responsibilities relating to: The integrity of the financial statements of the Company The qualifications and independence of the Companys independent auditor, an","filed_date":"2022-03-11","accession":"0001104659-22-032911","full_text":"https://origin.rootz.global/static/filing/0001104659-22-032911.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":31,"context":"in the accompanying Proxy Statement to serve one-year terms expiring at the Annual Meeting of Shareholders in 2023; 2. To hold a non-binding advisory vote to approve the compensation of the Companys named executive officers; 3. To hold a non-binding advisory vote to approve the frequency of the advisory vote on named executive officer compensation; 4. To ratify the selection of PricewaterhouseCoopers LLP as the Compa","filed_date":"2022-03-11","accession":"0001104659-22-032911","full_text":"https://origin.rootz.global/static/filing/0001104659-22-032911.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":29,"context":"onstruction in Gomez Palacio, Durango, Mexico. The facility was sold as part of the Mining Solutions Transaction. We also incurred $15 million of employee-related separation liabilities under various restructuring programs and $10 million of asset-related impairment charges in our Advanced Performance Materials segment, as well as $12 million of charges in connection with our decision to exit the Aniline business and","filed_date":"2022-02-11","accession":"0001564590-22-004791","full_text":"https://origin.rootz.global/static/filing/0001564590-22-004791.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_concentration","strength":100,"match_count":1,"context":"respective industries. Our sales are not materially dependent on any single customer. As of December 31, 2021, no one individual customer represented more than 10% of our consolidated net sales, and one customer represented approximately 6% of our total outstanding accounts and notes receivables balance. We are a different kind of chemistry company, driven by our vision to create a better world through the power of our chemistry. Our wo","filed_date":"2022-02-11","accession":"0001564590-22-004791","full_text":"https://origin.rootz.global/static/filing/0001564590-22-004791.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":30,"context":"ies alleging harm to the general public and damages to natural resources. Various factors or developments in these nationwide trends or in the actions could result in future charges that could have a material adverse effect on us. An adverse outcome in any one or more of these matters could be material to our financial results and/or stock price, and could adversely impact the value of any of our brands that are associa","filed_date":"2022-02-11","accession":"0001564590-22-004791","full_text":"https://origin.rootz.global/static/filing/0001564590-22-004791.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":16,"context":"tiated logistics capabilities. In early 2021, we began a strategic review of our Mining Solutions business, which included our sodium cyanide and hydrogen cyanide product lines. On July 26, 2021, we entered into a definitive agreement with Manchester Acquisition Sub LLC, a Delaware limited liability company and a subsidiary of Draslovka Holding a.s., to sell our Mining Solutions business and completed the sale on December 1, 2021","filed_date":"2022-02-11","accession":"0001564590-22-004791","full_text":"https://origin.rootz.global/static/filing/0001564590-22-004791.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":23,"context":"| 16 | | | | Total restructuring, asset-related, and other charges | | $ | 3 | | | $ | 9 | | | $ | 4 | | | $ | 37 | | | The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and nine months ended September 30, 2021 and 2020. | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | | 2021 | | |","filed_date":"2021-11-05","accession":"0001564590-21-054925","full_text":"https://origin.rootz.global/static/filing/0001564590-21-054925.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":23,"context":"| 11 | | | | Total restructuring, asset-related, and other charges | | $ | 5 | | | $ | 17 | | | $ | | | | $ | 28 | | | The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and six months ended June 30, 2021 and 2020. | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | | | | 2021 | | | 2020 | | | 20","filed_date":"2021-07-30","accession":"0001564590-21-039525","full_text":"https://origin.rootz.global/static/filing/0001564590-21-039525.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":18,"context":"ted charges | | | | | | | 1 | | | | Total restructuring, asset-related, and other charges | | $ | (5 | ) | | $ | 11 | | | The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three months ended March 31, 2021 and 2020. | | | Three Months Ended March 31, | | | | | | 2021 | | | 2020 | | | | Restructuring charges: | | | | | |","filed_date":"2021-05-05","accession":"0001564590-21-023483","full_text":"https://origin.rootz.global/static/filing/0001564590-21-023483.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":28,"context":"ccompanying Proxy Statement to serve one-year terms expiring at the virtual Annual Meeting of Shareholders in 2022; 2. To hold a non-binding advisory vote to approve the compensation of the Companys named executive officers; 3. To ratify the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for fiscal year 2021; 4. To approve amendments to the Amended and Restated C","filed_date":"2021-03-12","accession":"0001104659-21-035587","full_text":"https://origin.rootz.global/static/filing/0001104659-21-035587.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":35,"context":"utions facility currently under construction in Gomez Palacio, Durango, Mexico. We also incurred $15 million of net charges in connection with employee-related separation liabilities under our recent restructuring programs. We incurred $10 million of asset-related charges in connection with various property, plant, and equipment and other asset impairments in our Advanced Performance Materials segment, as well as $12","filed_date":"2021-02-12","accession":"0001564590-21-005805","full_text":"https://origin.rootz.global/static/filing/0001564590-21-005805.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":27,"context":"ies alleging harm to the general public and damages to natural resources. Various factors or developments in these nationwide trends or in the actions could result in future charges that could have a material adverse effect on us. An adverse outcome in any one or more of these matters could be material to our financial results and/or stock price, and could adversely impact the value of any of our brands that are associa","filed_date":"2021-02-12","accession":"0001564590-21-005805","full_text":"https://origin.rootz.global/static/filing/0001564590-21-005805.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":17,"context":"eir professional experience. Mark P. Vergnano, age 63, serves as our President and CEO. Prior to joining Chemours, he held roles of increasing responsibility at EID. In October 2009, Mr. Vergnano was appointed Executive Vice President of EID and was responsible for multiple businesses and functions, including the businesses in the Chemours segment: EID Chemicals and Fluoroproducts and Titanium Technologies. In June 2006, he was na","filed_date":"2021-02-12","accession":"0001564590-21-005805","full_text":"https://origin.rootz.global/static/filing/0001564590-21-005805.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":29,"context":"12 | | | | Total restructuring, asset-related, and other charges | | $ | 9 | | | $ | 34 | | | $ | 37 | | | $ | 49 | | | The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and nine months ended September 30, 2020 and 2019. | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | | 2020 | | |","filed_date":"2020-11-04","accession":"0001564590-20-050526","full_text":"https://origin.rootz.global/static/filing/0001564590-20-050526.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":24,"context":"| 10 The Chemours Company Notes to the Interim Consolidated Financial Statements (Unaudited) (Dollars in millions, except per share amounts) The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and six months ended June 30, 2020 and 2019. | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | | | | 2020 | | | 2019 | | | 20","filed_date":"2020-07-31","accession":"0001564590-20-035206","full_text":"https://origin.rootz.global/static/filing/0001564590-20-035206.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":23,"context":"| 10 The Chemours Company Notes to the Interim Consolidated Financial Statements (Unaudited) (Dollars in millions, except per share amounts) The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three months ended March 31, 2020 and 2019. | | | Three Months Ended March 31, | | | | | | 2020 | | | 2019 | | | | Restructuring and other charges: | | |","filed_date":"2020-05-06","accession":"0001564590-20-021955","full_text":"https://origin.rootz.global/static/filing/0001564590-20-021955.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":27,"context":"in the accompanying Proxy Statement to serve one-year terms expiring at the Annual Meeting of Shareholders in 2021; 2. To hold a non-binding advisory vote to approve the compensation of the Companys named executive officers; 3. To ratify the selection of PricewaterhouseCoopers LLP as the Companys independent registered public accounting firm for fiscal year 2020; 4. To vote on a shareholder proposal on a Board Adviso","filed_date":"2020-03-13","accession":"0001104659-20-032960","full_text":"https://origin.rootz.global/static/filing/0001104659-20-032960.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":41,"context":"bles Report SCHEDULES SCHEDULE ICommitments SCHEDULE IIMail-Boxes SCHEDULE IIINotice Addresses SCHEDULE IVApproved Foreign Countries SCHEDULE VInitial Schedule of Sold Receivables SCHEDULE 1.02Parent Material Adverse Effect; Servicer Material Adverse Effect SCHEDULE 3.06Proceedings SCHEDULE 7.01(l)UCC Details SCHEDULE 8.04(f)Location of Records This AMENDED AND RESTATED RECEIVABLES PURCHASE AGREEMENT (as amended, restat","filed_date":"2020-03-10","accession":"0001564590-20-009681","full_text":"https://origin.rootz.global/static/filing/0001564590-20-009681.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":24,"context":", net in the consolidated statements of operations. At December 31, 2019, the projected benefit obligations associated with the plans active employees remained on our consolidated balance sheet. 2019 Restructuring Program In an effort to better align our cost structure with market opportunities, we recorded net severance charges of $22 million during the year ended December 31, 2019. Impacted employees are subject to","filed_date":"2020-02-14","accession":"0001564590-20-004829","full_text":"https://origin.rootz.global/static/filing/0001564590-20-004829.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"risk_factor","strength":100,"match_count":24,"context":"ies alleging harm to the general public and damages to natural resources. Various factors or developments in these nationwide trends or in the actions could result in future charges that could have a material adverse effect on us. An adverse outcome in any one or more of these matters could be material to our financial results and/or stock price, and could adversely impact the value of any of our brands that are associa","filed_date":"2020-02-14","accession":"0001564590-20-004829","full_text":"https://origin.rootz.global/static/filing/0001564590-20-004829.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"strategic_event","strength":100,"match_count":20,"context":"Mark P. Vergnano, age 62, serves as our President and Chief Executive Officer (CEO). Prior to joining Chemours, he held roles of increasing responsibility at DuPont. In October 2009, Mr. Vergnano was appointed Executive Vice President of DuPont and was responsible for multiple businesses and functions, including the businesses in the Chemours segment: DuPont Chemicals and Fluoroproducts and Titanium Technologies. In June 2006, he","filed_date":"2020-02-14","accession":"0001564590-20-004829","full_text":"https://origin.rootz.global/static/filing/0001564590-20-004829.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":26,"context":"| 11 The Chemours Company Notes to the Interim Consolidated Financial Statements (Unaudited) (Dollars in millions, except per share amounts) The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and nine months ended September 30, 2019 and 2018. | | | Three Months Ended September 30, | | | Nine Months Ended September 30, | | | | | | 2019 | | |","filed_date":"2019-11-05","accession":"0001564590-19-040478","full_text":"https://origin.rootz.global/static/filing/0001564590-19-040478.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."},{"ticker":"CC","company":"Chemours Co","exchange":"NYSE","sector":"Chemicals & Allied Products","signal_type":"restructuring","strength":100,"match_count":15,"context":"| 10 The Chemours Company Notes to the Interim Consolidated Financial Statements (Unaudited) (Dollars in millions, except per share amounts) The following table sets forth the impacts of the Companys restructuring programs to segment earnings for the three and six months ended June 30, 2019 and 2018. | | | Three Months Ended June 30, | | | Six Months Ended June 30, | | | | | | 2019 | | | 2018 | | | 20","filed_date":"2019-08-02","accession":"0001564590-19-028394","full_text":"https://origin.rootz.global/static/filing/0001564590-19-028394.html","verify":"Read the filing at the full_text URL and search for the context string to verify this signal."}],"origin":{"leaf":"0502afc25b6e68bb03ca4ffa76077aa2d5c35888dd1987ce0c97fd06cca8710c","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"1c7aee2ea563fb67686191bed72e5d6339a107e2c2482675ad961ff1d1132f29","parent":null,"source":"signal_search","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256() || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":61,"hourly_limit":500,"remaining":439,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}